Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Minimal disease in the sentinel lymph node: how to best measure sentinel node micrometastases to predict risk of additional non-sentinel lymph node disease.

Kumar S, Bramlage M, Jacks LM, Goldberg JI, Patil SM, Giri DD, Van Zee KJ.

Ann Surg Oncol. 2010 Nov;17(11):2909-19. doi: 10.1245/s10434-010-1115-z. Epub 2010 Jun 9.

PMID:
20532987
2.

Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.

Changsri C, Prakash S, Sandweiss L, Bose S.

Breast J. 2004 Sep-Oct;10(5):392-7.

PMID:
15327491
3.
4.

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.

Newman EA, Sabel MS, Nees AV, Schott A, Diehl KM, Cimmino VM, Chang AE, Kleer C, Hayes DF, Newman LA.

Ann Surg Oncol. 2007 Oct;14(10):2946-52. Epub 2007 May 19.

PMID:
17514407
5.

Identification and evaluation of axillary sentinel lymph nodes in patients with breast carcinoma treated with neoadjuvant chemotherapy.

Cohen LF, Breslin TM, Kuerer HM, Ross MI, Hunt KK, Sahin AA.

Am J Surg Pathol. 2000 Sep;24(9):1266-72.

PMID:
10976701
6.

Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.

Joseph KA, El-Tamer M, Komenaka I, Troxel A, Ditkoff BA, Schnabel F.

Arch Surg. 2004 Jun;139(6):648-51.

PMID:
15197092
7.

Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.

Langer I, Guller U, Viehl CT, Moch H, Wight E, Harder F, Oertli D, Zuber M.

Ann Surg Oncol. 2009 Dec;16(12):3366-74. doi: 10.1245/s10434-009-0660-9. Epub 2009 Sep 4.

PMID:
19760047
8.

Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.

Choi SH, Barsky SH, Chang HR.

Breast J. 2003 May-Jun;9(3):153-62.

PMID:
12752622
9.

Role for sentinel lymph node dissection in the management of large (> or = 5 cm) invasive breast cancer.

Chung MH, Ye W, Giuliano AE.

Ann Surg Oncol. 2001 Oct;8(9):688-92.

PMID:
11597008
10.

Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.

Mustać E, Matusan-Ilijas K, Marijić B, Smokvina M, Jonjić N.

Int J Surg Pathol. 2010 Feb;18(1):36-41. doi: 10.1177/1066896909332113. Epub 2009 May 15.

PMID:
19448065
11.

The characteristics of the sentinel lymph node metastasis in predicting the axillary lymph node status in patients with breast carcinoma.

Olszewski WP, Szumera-Ciećkiewicz A, Piechocki J, Towpik E, Olszewski WT.

Pol J Pathol. 2009;60(3):138-43.

PMID:
20069508
12.

Clinical implications of occult metastases and isolated tumor cells in sentinel and non-sentinel lymph nodes in early breast cancer patients: serial step section analysis with long-term follow-up.

Takeshita T, Tsuda H, Moriya T, Yamasaki T, Asakawa H, Ueda S, Sato K, Aida S, Tamai S, Matsubara O, Hase K, Yamamoto J.

Ann Surg Oncol. 2012 Apr;19(4):1160-6. doi: 10.1245/s10434-011-2085-5. Epub 2011 Oct 12.

PMID:
21989659
13.

Predictors of non-sentinel lymph node metastasis in breast cancer patients.

Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE; ALMANAC Trialists Group.

Eur J Cancer. 2004 Jul;40(11):1731-7.

PMID:
15251163
14.

Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node.

Meattini I, Saieva C, Bertocci S, Francolini G, Zei G, De Luca Cardillo C, Scotti V, Greto D, Bonomo P, Orzalesi L, Bianchi S, Livi L.

Tumori. 2015 Jan-Feb;101(1):78-83. doi: 10.5301/tj.5000220. Epub 2015 Jan 24.

PMID:
25702658
16.

The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.

Fan YG, Tan YY, Wu CT, Treseler P, Lu Y, Chan CW, Hwang S, Ewing C, Esserman L, Morita E, Leong SP.

Ann Surg Oncol. 2005 Sep;12(9):705-11. Epub 2005 Aug 4. Erratum in: Ann Surg Oncol. 2005 Nov;12(11):952.

PMID:
16079953
17.

Second echelon node predicts metastatic involvement of additional axillary nodes following sentinel node biopsy in early breast cancer.

Bassi KK, Seenu V, Ballehaninna UK, Parshad R, Chumber S, Dhar A, Gupta SD, Kumar R, Srivastava A.

Indian J Cancer. 2006 Jul-Sep;43(3):103-9.

18.

Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.

Orsoni M, Clerc J, Golfier F, Cortet M, Raudrant D, Krauth JS.

Eur J Obstet Gynecol Reprod Biol. 2011 Oct;158(2):334-7. doi: 10.1016/j.ejogrb.2011.05.020. Epub 2011 Jun 12.

PMID:
21669485
19.

Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.

Ouldamer L, Arbion F, Balagny A, Fourquet F, Marret H, Body G.

Breast. 2013 Oct;22(5):787-92. doi: 10.1016/j.breast.2013.02.004. Epub 2013 Mar 7.

PMID:
23473772
20.

Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?

Zakaria S, Pantvaidya G, Reynolds CA, Grant CS, Sterioff S, Donohue JH, Farley DR, Hoskin TL, Degnim AC.

Surgery. 2008 May;143(5):641-7. doi: 10.1016/j.surg.2007.10.023. Epub 2008 Feb 13.

PMID:
18436012
Items per page

Supplemental Content

Write to the Help Desk